- Details
- Description
-
Packaging Size30t/bottle
-
Strength100mg&150mg&200mg
-
CompositonMomelotinib
-
TreatmentMyelofibrosis with Anemia
-
FormTablet
-
BrandMolotinib
-
Quantity Unit100mg&150mg&200mg*30T/Box
-
ManufacturerTongmeng (Lao) Pharmaceutical & Food Co., Ltd.(TLPH)
About Momelotinib
ONE PILL, ONCE DAILY
Momelotinib is an anticancer medication used for the treatment of myelofibrosis. It is a Janus kinase inhibitor and it is taken by mouth.
Overall, momelotinib provides spleen, symptom, and anemia benefits to JAK inhibitor-naive patients with myelofibrosis regardless of baseline hemoglobin level, and greater anemia-related benefits vs. ruxolitinib in patients with hemoglobin <12 g/dL